Recent studies on the regenerating newt limb, using cells transfected with chimeric retinoic acid receptors that can be activated by thyroid hormone, have provided unique insights into the function of specific retinoic acid receptor isoforms.
Retinoic acid is thus a molecule required for the proper development of the embryo, and some of the most interesting effects on embryos have been seen in developing and regenerating limbs. Excess retinoic acid administered to the developing chick limb bud induces the growth of an extra limb, and the two limbs grow side-by-side in mirror symmetry [3, 4] . In the regenerating amphibian limb, retinoic acid induces an extra limb to grow on the end of the original one, making it twice as long [3, 4] . Most remarkably, retinoic acid can transform regenerating frog tadpole tails into limbs [7] .
How can one molecule have such incredibly diverse effects on developing cells and tissues? Even within a single system, the regenerating amphibian limb, during the process of inducing extra limb outgrowth retinoic acid has at least 12 distinguishable effects on the cells of the blastema, such as excessive dedifferentiation, cell clumping, epidermal metaplasia, keratin changes, and so on [8] . At least part of the explanation for this range of effects has come from studying the mechanism of action of retinoids in the cell, and the discovery of a family of nuclear retinoic acid receptors (RARs) [9, 10] . These nuclear receptors act as ligand-activated transcription factors, and have provided a molecular basis for the pleiotropic effects of retinoids in the following way. There are three RAR genes -RAR␣, RAR␤ and RAR␥ -and several isoforms of each gene, the major ones being ␣ 1 , ␣ 2 , ␤ 1 , ␤ 2 , ␤ 3 , ␤ 4 , ␥ 1 and ␥ 2 . Within the regenerating newt limb, five RAR isoforms are expressed: ␣ 1 , ␣ 2 , ␦ 1a , ␦ 1b and ␦ 2 (the newt ␦ is equivalent to the mammalian ␥). A second family of receptors was subsequently discovered, the so-called retinoid X receptors (RXRs), with three family members (␣, ␤ and ␥) and a similar range of isoforms. The RARs and RXRs can heterodimerize before binding to retinoic acid response elements in the DNA, and with all these isoforms available the number of possible combinations is enormous.
Do individual isoforms have a function?
Two pieces of evidence have suggested that individual RAR and RXR isoforms may have unique functions in developing embryos and adult tissues. Firstly, amino-acid sequence comparisons have revealed that the interspecies conservation of a given RAR family member is greater than the similarity between the three RAR genes within a given species, and this is particularly so in the amino-terminal 'A regions' of the various isoforms. Secondly, each RAR isoform has a distinct spatio-temporal expression pattern in the developing embryo.
On the basis of gene expression data from many studies of the mouse embryo, one would suggest the following functions for each RAR. RAR␣ is generally considered to be ubiquitous, but in early embryos it would have a function in neural tube development from the anterior hindbrain backwards, in migrating neural crest and some of its derivatives, in the dental epithelium and in several individual organs (liver, thyroid and thymus). RAR␤ would function in endoderm development, in presomitic mesoderm, in motorneuron development, in the heart, in the frontonasal mass, in the eyes (particularly the retina and optic nerve), in interdigital cell death and in various organ epithelia (tracheal, bronchial, genital and olfactory). RAR␥ would function in neurulation, in the structures that make up the face, in dental mesenchyme, in cartilage differentiation and in the skin.
It must be remembered, however, that we know nothing about the protein distribution of these receptors in the mammalian embryo: the data described above are all patterns of transcription, detected by in situ hybridization and with no resolution at the cellular level. In the only immunohistological study performed to date, using antibodies to the ␦ 1 isoform in the newt limb [11] , it was found that 50 % of nuclei in all differentiated tissues were immunoreactive, and in the regenerating blastema the percentage of immunoreactive cells increased.
Two different approaches have been used to test the function of the RARs and their isoforms. The most obvious one is to use homologous recombination techniques in mice to 'knock out' the RAR genes one by one and look for abnormalities in the embryos. An alternative is to put each successively under the control of an alternative ligand and then see which of the pleiotropic effects the alternative ligand induces. It should be emphasized that these are not equivalent approaches: the former is concerned with the function of endogenous isoforms, whereas the latter is concerned with how the isoforms function in the presence of excess retinoic acid.
Knockouts Surprisingly, when individual RAR isoforms -RAR␣ 1 , RAR␤ 2 and RAR␥ 2 -are genetically knocked out, the phenotype of the mouse embryo is unaltered [12] . More surprisingly still, normal embryos are produced when all of the RAR␤ isoforms are knocked out simultaneously. A knockout of all the RAR␣ isoforms does give a phenotype -postnatal lethality, testis degeneration and webbed digits -as does a knockout of all the RAR␥ isoforms, which gives postnatal lethality, growth deficiency, transformations of certain vertebrae, malformations of tracheal cartilages, Harderian gland agenesis and squamous metaplasia of the seminal vesicles and prostate. None of these phenotypes is what might have been expected from the gene expression patterns. It is not until isoforms for two of the three RAR genes are knocked out together that embryonic malformations appear which resemble those associated with vitamin A deficiency. Thus, abnormalities of the respiratory tract, heart outflow tract, aortic arch, genital tract and eye appear in such double mutants as ␤ 2 /␥, ␣/␥, ␣/␤ 2 , and so on. In addition, other abnormalities appear which are not associated with the vitamin-deficiency syndrome, such as skeletal and glandular abnormalities.
These results are clearly contrary to the prediction that each isoform has a specific function. Furthermore, the glaring omission from all these embryonic abnormalities is the best-known and pharmaceutically important effect on skin (and wrinkles): all the mutant mice have failed to reveal any dramatic changes in the morphology of the epidermis. The standard explanation for these contrasting results is functional redundancy at the molecular leveldifferent receptors can substitute for each other -which implies that receptor isoforms do not have individual functions. But there is also good evidence which seems to support the conclusion that individual isoforms do indeed have distinct functions.
Chimeric receptors
In contrast to the results with knockouts, the approach that Brockes and his colleagues have taken in studies of the regenerating newt limb has produced results which do demonstrate functions for individual isoforms. The method used is to swap the ligand-binding domain of a particular RAR isoform with that taken from a thyroid hormone receptor, thereby making a chimeric receptor Dispatch 791
Figure 1
The assay system of intercalary regeneration used by Pecorino, Entwistle and Brockes [17] to determine which receptor isoform is responsible for proximalization of distal blastemal cells; (a) is an explanation of cellular behaviour during normal intercalary regeneration, (b) is what happens to the cellular contributions when the distal blastema has been treated with retinoic acid. that is responsive to thyroid hormone rather than retinoic acid, but which still activates the appropriate retinoic acidresponsive genes. A range of such chimeric receptors are then transfected one by one back into newt limb blastemal cells, either in vitro or in vivo, using biolistics (biolistics has been reviewed previously in Current Biology [13] ).
In this way Schilthius, Gann and Brockes [14] showed that when the ␣ 1 chimera was transfected into blastemal cells they became growth-inhibited (one of the 12 characterized effects of retinoic acid on the blastema) in response to thyroid hormone. Only the ␣ 1 chimera behaved in this way; there was no response with other chimeras. Furthermore, the region required for this specificity proved to be the A region of the receptor [15] . Thus, the conclusion from this study was that the function of RAR␣ 1 is to induce growth inhibition in response to retinoic acid. A similar experiment by Pecorino, Lo and Brockes [16] , examining the induction of an antibody marker in the wound epidermis in response to retinoic acid, produced the clear result that this cellular behaviour was induced by the ␦ 1 isoform.
The latest chapter in this story, reported in the May issue of Current Biology [17] , is the most exciting result so far because it concerns the effect that retinoic acid has on the patterning of blastemal cells. When retinoic acid induces a complete limb to regrow from an amputation plane through the wrist or forearm, thus generating two limbs in tandem, it respecifies distal (wrist or lower arm) blastemal cells to become more proximal (upper arm or shoulder). It is known that this involves a change in the cell-surface properties of blastema cells because the behaviour of retinoic acid-treated distal cells changes to become more like proximal cells in an assay known as intercalary regeneration (see Fig. 1 ). Intercalary regeneration is the process whereby the gap is 'filled in' when a distal blastema is grafted to a proximal stump (Fig. 1a) . Normally the cells that do this filling-in come entirely from the proximal stump, and the cells of the distal grafted blastema make no contribution. But when the distal grafted blastema has been treated with retinoic acid, the cells become proximalized and make a significant contribution to the process of filling-in (Fig. 1b) .
Pecorino, Entwistle and Brockes [17] asked which RAR isoform is responsible for this pattern respecification by retinoic acid. They made chimeric receptors for each of the five isoforms, transfected them individually into distal blastemas and treated the blastemas not with retinoic acid but with thyroid hormone. The distribution of the transfected cells from the distal blastema in the intercalary regenerate was analysed using fluorescence and a confocal microscope. Only when the cells were transfected with the chimeric ␦ 2 receptor did the distribution of cells in the intercalary regenerate change from being distal (normal and not responding to thyroid hormone with pattern changes) to proximal (responding to thyroid hormone with pattern changes). The conclusion is therefore that the ␦ 2 isoform is responsible for the proximalization of blastemal cells by retinoic acid.
Thus, the work of Brockes and colleagues on newt limb regeneration has so far produced a unique function for three of the five RAR isoforms known to be present. The ␣ 1 isoform mediates the growth inhibition of blastemal cells; the ␦ 1 isoform mediates the antigenic change of wound epidermis cells; and the ␦ 2 isoform mediates positional change in the proximo-distal axis. The clear conclusion from this work is that RAR isoforms have unique functions and no redundancy. These researchers are now in a strong position to identify the target genes that these isoforms activate, and so to reach the ultimate goalidentification of the molecular mechanisms of positional change.
In the work on the mammalian embryo, such isoform specificity has been concluded from analyses of their tissue distribution and from amino-acid sequence comparisons, but experimental tests using gene knockouts have only demonstrated redundancy, not specific functions. A solution to the apparent contradiction between these results and those of Brockes and colleagues can be proposed if we assume that the knockout results have revealed cellular redundancy, but not molecular redundancy. Thus, if an organ or embryonic field of cells normally develops as a result of an interaction between at least two tissues, and if the cells of each of these tissues express a unique RAR/RXR isoform profile, with each isoform performing a unique function, then knocking out a single isoform might prevent the function of that group of cells in which the isoform is expressed, but the organ might be able to develop successfully without the contribution of these cells which simply cease to function . This cellular complementation would be an example of a classical embryological phenomenon known as 'double assurance', which occurs in skeletal muscle lineages and explains the lack of phenotype in knockouts of individual myogenic genes [18] . It seems highly relevant to the results described here for the retinoid receptors.
